Inactive Instrument

Insiders Albireo Pharma, Inc.

Equities

ALBO

US01345P1066

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

Albireo Pharma, Inc. Announces Board Changes	23-03-02	CI
Insider Sell: Albireo Pharma	23-01-20	MT
Albireo Pharma, Inc. Appoints Paul Streck as Chief Medical Officer and Craig Hopkinson to its Board of Directors	22-12-06	CI
Albireo Pharma, Inc. Announces the Appointments of Habib Dable and Susan Alesina to its Board of Directors	22-08-10	CI
Albireo Pharma, Inc. Announces Resignation of Roger A. Jeffs as Independent Director	22-01-05	CI
Albireo Pharma, Inc. Announces Executive Changes	21-12-09	CI
Albireo Pharma, Inc. Announces Constantine Chinoporos as Chief Business Officer	21-12-02	CI
Albireo Expands Leadership with Joan Connolly as Chief Technology Officer	21-04-13	CI
Albireo Pharma, Inc. Appoints Michelle Graham as Chief Human Resources Officer	19-11-04	CI
Albireo Pharma, Inc. Appoints Pamela Stephenson as Chief Commercial Officer, Effective March 25, 2019	19-03-21	CI
Albireo Pharma, Inc. Announces Executive Changes	18-10-10	CI
Albireo Pharma, Inc Announces Executive Changes	18-07-25	CI
Albireo Appoints Jason G. Duncan as General Counsel and Secretary	18-06-18	CI
Albireo Pharma, Inc. Elects Anne Klibanski and Stephanie Okey to Board of Directors	18-06-08	CI
Peter A. Zorn, Esq. Steps Down from as Chief Corporate Officer, General Counsel and Secretary of Albireo Pharma, Inc., Effective April 1, 2018	18-03-06	CI
Albireo Pharma, Inc. Appoints Roger Jeffs to the Board of Directors	17-11-14	CI
Albireo Pharma, Inc. Announces Board Changes	17-09-28	CI
Albireo Pharma, Inc. Promotes Peter A. Zorn to Chief Corporate Officer	17-01-27	CI
Albireo Pharma, Inc. Appoints Martha J. Carter as Chief Regulatory Officer	16-11-29	CI
Albireo Limited Appoints Ron Cooper as President and Chief Executive Officer	15-09-23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Albireo Pharma, Inc.

Equities

ALBO

US01345P1066

Insiders

Filters